Holen Sie sich die Stockscreener-App
12.44
8.55%
0.98
Vorhandelsmarkt:
12.43
-0.010
-0.08%
Schlusskurs vom Vortag:
$11.46
Offen:
$11.48
24-Stunden-Volumen:
5.18M
Relative Volume:
1.83
Marktkapitalisierung:
$2.65B
Einnahmen:
$61.10M
Nettoeinkommen (Verlust:
$-138.36M
KGV:
-9.2148
EPS:
-1.35
Netto-Cashflow:
$-90.59M
1W Leistung:
+2.47%
1M Leistung:
+14.13%
6M Leistung:
+48.45%
1J Leistung:
+31.22%
1-Tages-Spanne:
$11.41
$13.00
1-Wochen-Bereich:
$11.14
$13.00
52-Wochen-Spanne:
$5.80
$13.85
Ocular Therapeutix Inc Stock (OCUL) Company Profile
Firmenname
Ocular Therapeutix Inc
Sektor
Branche
Telefon
781-357-4000
Adresse
15 CROSBY DRIVE, BEDFORD, MA
Vergleichen Sie OCUL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OCUL
Ocular Therapeutix Inc
|
12.44 | 2.44B | 61.10M | -138.36M | -90.59M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-15 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-04-08 | Eingeleitet | William Blair | Outperform |
| 2025-03-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-03-11 | Eingeleitet | Needham | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-06-20 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2024-02-09 | Eingeleitet | BofA Securities | Buy |
| 2023-04-21 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-08-10 | Fortgesetzt | Berenberg | Buy |
| 2021-08-10 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-12-28 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-11-13 | Bestätigt | Raymond James | Strong Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-03 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-05-21 | Herabstufung | Cowen | Outperform → Market Perform |
| 2019-05-21 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2018-12-03 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-11-15 | Eingeleitet | Raymond James | Strong Buy |
| 2018-09-07 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-10-24 | Eingeleitet | Guggenheim | Buy |
| 2017-07-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-07-12 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-06-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2017-02-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2016-11-15 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-08-11 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2016-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-10-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2015-08-13 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Ocular Therapeutix Inc Aktie (OCUL) Neueste Nachrichten
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance Singapore
What sentiment indicators say about Ocular Therapeutix Inc. stockWeekly Trade Recap & High Return Trade Opportunity Guides - Newser
How Ocular Therapeutix Inc. stock reacts to inflationary pressuresDollar Strength & Reliable Breakout Forecasts - Newser
How forex fluctuations impact Ocular Therapeutix Inc. (0OT) stockJuly 2025 PostEarnings & Weekly Top Gainers Trade List - Newser
OCUL: Phase III trials target a first-in-class superiority label and durable retinal disease therapy - TradingView
Discipline and Rules-Based Execution in OCUL Response - news.stocktradersdaily.com
Is Ocular Therapeutix Inc. stock cheap compared to fundamentals2025 Year in Review & Stepwise Trade Signal Guides - Newser
Hedge Fund Bets: What is the fair value of Ocular Therapeutix Inc. stock now2025 Sector Review & Smart Swing Trading Alerts - moha.gov.vn
Highs Report: Why analysts raise outlook for Ocular Therapeutix Inc. (0OT) stock2025 Volatility Report & Safe Swing Trade Setup Alerts - moha.gov.vn
Ocular Therapeutix CEO Dugel sells $235k in stock By Investing.com - Investing.com Australia
How HELIOS-3 Phase 3 Trial Enrollment at Ocular Therapeutix (OCUL) Has Changed Its Investment Story - Sahm
OCUL: HC Wainwright & Co. Reiterates Buy Rating with $19 Price T - GuruFocus
HC Wainwright & Co. Reiterates Ocular Therapeutix (OCUL) Buy Recommendation - Nasdaq
Ocular Therapeutix Begins Phase 3 Registrational Program to Potentially Treat Non-Proliferative Diabetic Retinopathy - marketscreener.com
Ocular Therapeutix (OCUL) Advances Diabetic Retinopathy Treatmen - GuruFocus
Ocular Therapeutix™ Announces First Patient Randomized in HELIOS-3 Phase 3 Registrational Program for AXPAXLI™ in NPDR - The Manila Times
Ocular Therapeutix Reports Q3 2025 Financial Results - MSN
Behavioral Patterns of OCUL and Institutional Flows - news.stocktradersdaily.com
Why Ocular Therapeutix Inc. (0OT) stock remains stableIndex Update & Reliable Intraday Trade Plans - newser.com
Will Ocular Therapeutix Inc. stock see PE expansionWeekly Profit Summary & Weekly Top Performers Watchlists - newser.com
Is Ocular Therapeutix Inc. stock a safe haven assetJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com
Will Ocular Therapeutix Inc. stock pay special dividendsWeekly Investment Recap & Entry Point Confirmation Signals - newser.com
Wall Street Analysts Think Ocular Therapeutix (OCUL) Could Surge 82.48%: Read This Before Placing a Bet - sharewise.com
Published on: 2025-11-20 06:23:38 - newser.com
Why analysts recommend Ocular Therapeutix Inc. (0OT) stockInflation Watch & Technical Pattern Alert System - newser.com
Why Ocular Therapeutix Inc. (0OT) stock stays on top picksRate Hike & High Return Stock Watch Alerts - newser.com
Is this a good reentry point in Ocular Therapeutix Inc.2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com
How Ocular Therapeutix Inc. (0OT) stock behaves in tightening cyclesWeekly Profit Analysis & AI Enhanced Trading Alerts - newser.com
Is Ocular Therapeutix Inc. stock near bottom after declineJuly 2025 Institutional & Intraday High Probability Alerts - newser.com
Will Ocular Therapeutix Inc. stock see insider buyingSell Signal & Long-Term Safe Investment Ideas - newser.com
Published on: 2025-11-19 13:52:30 - newser.com
Why Ocular Therapeutix Inc. (0OT) stock could be top winner2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com
Will Ocular Therapeutix Inc. stock deliver consistent dividendsQuarterly Trade Review & Real-Time Volume Surge Alerts - newser.com
Comparing Ocular Therapeutix Inc. in custom built stock radarsStop Loss & Growth Focused Stock Pick Reports - newser.com
Will Ocular Therapeutix Inc. stock go up soonMarket Trend Summary & Detailed Earnings Play Alerts - newser.com
Ocular Therapeutix (OCUL) Soars 5% Ahead of Health Conferences - MSN
Finanzdaten der Ocular Therapeutix Inc-Aktie (OCUL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):